Enhancement of radioresponse of murine tumors by ERK inhibitor.
Seong
Jinsil
J
Department of Radiation Oncology, Yonsei Cancer Center, Brain Korea 21 Project for Medical Science, Yonsei University Medical College, Seoul 120-752, Korea. jsseong@yumc.yonsei.ac.kr
Kim
Sung Hee
SH
Suh
Chang Ok
CO
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000528:radiation effects; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D002455:Cell Division / Q000187:drug effects; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005419:Flavonoids / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D051379:Mice; D008809:Mice, Inbred C3H; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors*
D004791:Enzyme Inhibitors; D005419:Flavonoids; D020928:Mitogen-Activated Protein Kinases; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one